In summary, this highlights DYRK2 inhibition by YK-2-69 as a promising combination to inhibit proliferation and promote apoptosis, which provides a “kill two birds with one stone” regimen of PCa. The gene discussed is DYRK2; the disease is posterior cortical atrophy.